PBAC Public Summary Documents – March 2021

Page last updated: 12 November 2021

Public Summary Documents relating to the March 2021 PBAC meeting.

• Abemaciclib: Tablet 150 mg, Tablet 100 mg, Tablet 50 mg; Verzenio®
• Aciclovir: Eye ointment 30 mg per g, 4.5 g; Xorox®
• Amino acid formula with fat, carbohydrate, vitamins, minerals, trace element and medium chain tryglycerides: Oral powder 800 g; Essential Care Jr®
• Atezolizumab: Solution concentrate for I.V. infusion 840 mg in 14 mL; Tecentriq®
• Avelumab (renal cell carcinoma): Solution concentrate for I.V. infusion 200 mg in 10 mL; Bavencio®
• Avelumab (urothelial carcinoma): Solution concentrate for I.V. infusion 200 mg in 10 mL; Bavencio®
• Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Mvasi®
• Brentuximab vedotin: Powder for I.V. infusion 50 mg; Adcetris®
• Brolucizumab: Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe; Beovu®
• Budesonide: Tablet (orally disintegrating) 1 mg; Jorveza®
• Burosumab: Injection 10 mg in 1 mL, Injection 20 mg in 1 mL, Injection 30 mg in 1 mL; Crysvita®
• Cabazitaxel: Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent; Cabazitaxel Ever Pharma®
• Cabotegravir and rilpivirine: Pack containing 1 injection of cabotegravir 600 mg in 3 mL and 1 injection of rilpivirine 900 mg in 3mL; Cabenuva®
• Ciclosporin: Eye drops 0.1%, single dose units 0.4 mL, 30; Ikervis®
• Darolutamide: Tablet 300 mg; Nubeqa®
• Decitabine and cedazuridine: Tablet containing decitabine 35 mg + cedazuridine 100 mg; Inqovi®
• Deutetrabenazine: Tablet 6 mg, Tablet 9 mg, Tablet 12 mg; Austedo®
• Elexacaftor+ tezacaftor + ivacaftor: Pack containing 56 tablets of elexacaftor 100 mg with tezacaftor 50 mg and ivacaftor 75 mg and 28 tablets of ivacaftor 150 mg; Trikafta®
• Encorafenib: Capsule 50 mg, Capsule 75 mg; Braftovi®
• Enzalutamide and abiraterone acetate: Enzalutamide: Capsule 40 mg; Xtandi®; Abiraterone: Tablet 500 mg, Tablet 250 mg; Zytiga®
• Eslicarbazepine: Tablet 800 mg; Zebinix®
• Evolocumab: Injection 420 mg in 3.5 mL single use pre-filled cartridge; Repatha®
• Gemtuzumab ozogamicin: Powder for injection 5 mg; Mylotarg®
• Glatiramer: Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe; Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe; Glatira®
• Guselkumab: Injection 100 mg in 1 mL single use pre-filled pen; Tremfya®
• High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate: Oral semi-solid, 100 g, 36; K.Yo®
• High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate: Oral powder 300 g; KetoCal 3:1®; KetoCal 4:1®
• Lacosamide: Tablet 50 mg, Tablet 100 mg, Tablet 150 mg, Tablet 200 mg, Oral solution 10 mg per mL, 200 mL; Vimpat®
• Melatonin: Tablet 1 mg, Tablet 5 mg; Slenyto®
• Nintedanib: Capsule 100 mg, Capsule 150 mg; Ofev®
• Niraparib: Capsule 100 mg; Zejula®
• Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
• Nivolumab and Ipilimumab; Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL Opdivo®; Ipilimumab: Injection concentrate for I.V. infusion 50 mg in 10 mL; Yervoy®
• Obeticholic acid: Tablet 5 mg, Tablet 10 mg; Ocaliva®
• Ofatumumab: Injection 20 mg in 0.4 mL single use pre-filled pen; Kesimpta®
• Olaparib: Tablet 150 mg, Tablet 100 mg; Lynparza®
• Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda®
• Ripretinib: Tablet 50 mg; Qinlock®
• Risdiplam: Powder for oral solution 0.75 mg per 1 mL, 80 mL; Evrysdi®
• Semaglutide: Solution for injection 2 mg in 1.5 mL pre-filled pen, Solution for injection 4 mg in 3 mL pre-filled pen; Ozempic®
• Tafamidis: Capsule 61 mg; Vyndamax®
• Teduglutide: Powder for injection 5 mg with diluent; Revestive®
• Teriparatide: Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled cartridge; Terrosa®
• Testosterone: Transdermal cream 50 mg per mL, 50 mL; AndroForte 5®
• Tetracosactide: Compound depot injection 1 mg in 1 mL; Synacthen®
• Tucatinib: Tablet 150 mg, Tablet 50 mg; Tukysa®
• Upadacitinib (ankylosing spondylitis): Tablet 15 mg; Rinvoq®
• Upadacitinib (severe psoriatic arthritis): Tablet 15 mg; Rinvoq®
• Ustekinumab: Injection 45 mg in 0.5 mL, Stelara®
• Venetoclax: Tablet 100 mg; Venclexta®